Angiogenesis, especially via VEGF and other cytokines, is implicated in the transition from steatosis to steatohepatitis (MASH) and ultimately HCC, even in non-cirrhotic livers. The gene discussed is VEGFA; the disease is metabolic dysfunction-associated steatohepatitis.